Invyncible Review
Semaglutide & tirzepatide GLP-1 weight-loss telehealth · Independently scored 8.1/10
Best for: compounded semaglutide or tirzepatide bought one vial at a time, with no subscription
Invyncible scores highest on the clinical side (which drugs it prescribes and how it doses) and lowest on follow-up care, and it serves 40 states. It charges from $149 a month; its compounded tirzepatide, at $180, is 33% below the $269 median among the sellers we compare.
Some of the links on this page earn us money. If you sign up with a provider after following one, that provider may pay GLP Watchdog a commission. Learn more
Covered by the monthly price
Medication
Not stated
Clinician visits
Not stated
Shipping
Not stated
Lab work
Not stated
Coaching
Not stated
Prices checked October 2026
Invyncible is a telemedicine network that prescribes compounded semaglutide and tirzepatide by the vial and leaves the dispensing to outside pharmacies. A semaglutide program lists at $192.50 for roughly five weeks and tirzepatide at $210 for four, with blends that add glycine and B12 from $149. Nationwide Telemedicine, LLC of St. Petersburg, Florida runs it. It does not serve 10 states.
Is Invyncible legit?
Yes. Invyncible is a real, operating US company, and we found no FDA warning letters issued to it. Its site shows LegitScript certification. We rate it 8.1/10 overall, across six areas from price to trust and safety. Legitimate is not the same as right for you, though: that part is a decision for you and a licensed clinician.
Is there an Invyncible promo or coupon code?
We know of no promo or coupon code for Invyncible. Its listed price is $149 a month. Coupon sites advertising "Invyncible discount codes" are not a source we can vouch for, and any genuine offer shows at checkout without a code.
See how Invyncible compares on our rankings of the best semaglutide providers and the best tirzepatide providers.
Vetted alternatives to Invyncible
Collective
Best for: flat any-dose pricing, if you can absorb a $199 annual membership on top
Editorial score · methodology
Embody
Best for: a flat compounded tirzepatide or semaglutide price at every dose, from a seller that names its pharmacies
Editorial score · methodology
Luvo Health
Best for: moving between compounded and brand without changing seller
Editorial score · methodology
Invyncible at a glance
- Type
- GLP-1 telehealth provider
- Medications
- Semaglutide, Tirzepatide
- Starting price
- $149/mo
- Availability
- 40 states
- FDA status
- No FDA warning letters found
How Invyncible scores
Six columns, each one computed from something Invyncible has published rather than from an opinion we formed: what it charges, which molecules it will dispense, what its record shows, and what the monthly figure actually buys. Where a seller keeps something back, such as its price or its pharmacy, the score reflects it. Every seller we review goes through the same six columns.
Value25%
7.9/10$180/month is 33% below the $269 median for compounded tirzepatide across the sellers we compare.
Effectiveness25%
10.0/10Dispenses semaglutide and tirzepatide, compounded only. Anchored to SURMOUNT-1 (tirzepatide, -20.9%) and STEP 1 (semaglutide, -14.9%).
User Experience15%
8.0/10A price is shown before the questionnaire starts.
Trust & Safety15%
7.5/10No pharmacy is named for its prescriptions. It shows a price before asking for health information. It lists the states it serves.
Accessibility10%
8.4/10Serves 40 of 50 states.
Support10%
5.0/10States too little about what the monthly cost covers to score the bundle. Held at the midpoint rather than assumed.
A seller that shows no price until after the medical intake loses points on User Experience and Trust & Safety, and its review says so. How we score →
What we checked on Invyncible
Last checked October 2026- Checked the listed price across 4 dose or plan tiers
- Checked state coverage: 40 states
- Checked FDA warning letters for Invyncible
Price, availability, and compliance here are read off the seller's own pages and off primary regulatory records, named in the sources below.
What signing up with Invyncible involves
What to expect on the way to a prescription: where the price appears, who fills the medication, and what the monthly price covers. It is not medical advice, and a clinician makes the prescribing decision.
- 1Invyncible shows a price on its own site before asking anything about you, so you can compare it with other sellers before you start a questionnaire.
- 2Ask Invyncible which pharmacy fills the prescription before you pay. The pharmacy's name is what lets you check its license.
- Lowest ongoing monthly price: tirzepatide $180, semaglutide $149. That leaves out membership fees, first-month rates and insurance copays.
- Invyncible serves 40 of 50 states, so check that yours is one of them.
- The medication is compounded, so it is not an FDA-approved product and has not been reviewed by the agency for safety, effectiveness or manufacturing quality.
Contacting Invyncible
- Phone
- 855-862-9510
- Hours
- Monday–Friday, 9am–5pm EST
Cancelling Invyncible
Taken from the terms Invyncible publishes. Terms change, so check the current policy before you subscribe.
- Cancel any time
- Yes
- Minimum commitment
- None
- Refund policy
- Payment is held as an authorization and released if the physician does not approve the prescription
- Early-termination fee
- None
Medications Invyncible lists
Invyncible lists compounded semaglutide and compounded tirzepatide. Each one has its own guide: how it works, the dosing schedule, the side effects that show up in practice, and what the trials measured.
Peptides Invyncible offers
Invyncible sells peptides beyond the GLP-1s. Tap one to read what the evidence says about it.
Pricing
Prices re-verified
Listed at $192.50 against a $275.00 list price. Programs are sold per vial with an approximate duration, not as a calendar month — see the review notes.
Listed at $210.00 against a $300.00 list price, the same for each of the five program strengths shown.
Listed at $149.00 against $350.00. Prepared by Strive Pharmacy. Not sold in Arkansas, California, Indiana, Minnesota, Oregon or South Carolina.
Listed at $180.00 against $325.00. A maintenance program covers 8 weeks.
Check the price yourself before you pay
Every figure here comes from Invyncible's own website, as of the date shown. Sellers move prices without announcing it, and promotional rates lapse, so confirm the standing cost on their site before committing.
In its favor
- Tirzepatide costs $180 a month, 33% below the $269 median for compounded tirzepatide across the sellers we compare
- Semaglutide costs $149 a month, 25% below the $199 median for compounded semaglutide across the sellers we compare
- Shows its price before the medical questionnaire, so you can compare it without handing over health information
- Serves 40 states
- We found no FDA warning letters issued to Invyncible
Against it
- Ask which pharmacy fills the prescription before you pay, so you can check its license
- Its semaglutide and tirzepatide are compounded rather than FDA-approved, so they have not been reviewed by the agency for safety, effectiveness or manufacturing quality
What Invyncible charges
The standing price at Invyncible is $149/month.
- Compounded semaglutide (injection): $192.50/month
- Compounded tirzepatide: $210/month
- Compounded semaglutide (vial): $149/month
- Compounded tirzepatide (with B12 and glycine): $180/month
For compounded tirzepatide, the median across the sellers we compare is $269/month, so Invyncible's $180 is genuinely below the middle, not just advertised that way. Before you pay, compare Invyncible's cancellation terms with other sellers' cancellation and refund policies.
Found, at about $149/month + membership, is the closest like-for-like alternative we review.
What Invyncible dispenses
Invyncible prescribes semaglutide (approved as Wegovy and Ozempic) and tirzepatide (approved as Zepbound and Mounjaro). Between them these are the pair carrying the strongest published outcome data. These are compounded preparations from a licensed pharmacy rather than approved pens, which is where the lower price comes from. A compounded drug is not FDA-approved as a finished product: the specific preparation has not been reviewed for safety, efficacy or manufacturing quality. The molecule can be the one in Ozempic and Wegovy; what differs is the formulation, the concentration and the dose ladder. Some of Invyncible's preparations are mixed with B12; why compounders add it separates what is established from what is only claimed.
Safety and disclosure
Invyncible tells you its price before you start the medical questionnaire and the 40 states it serves. We found no FDA warning letters issued to Invyncible. Because the medication is compounded, the most useful question to ask at intake is which licensed pharmacy fills the prescription. If Invyncible will not tell you, treat that as a warning sign. A 503A pharmacy answers to a state board and a 503B facility to the FDA; which one fills it changes what you can check. How we weigh oversight, disclosure and price is set out in our scoring methodology.
Invyncible also sells NAD+, and a 2026 systematic review found no outcomes trials of injected NAD+ for anti-aging or wellness.
Who should look elsewhere
- You want the FDA-approved pen specifically. Everything listed here is compounded.
- You need insurance to cover the cost. Check whether Invyncible bills your plan before you start.
It fits if
- the lowest standing monthly cost is what you are solving for
Our read
Invyncible competes on price without an obvious sacrifice elsewhere: $180/month for compounded tirzepatide, no FDA warning letters, and wide state coverage.
The Bottom Line
Invyncible scores highest on the clinical side (which drugs it prescribes and how it doses) and lowest on follow-up care, and it serves 40 states. It charges from $149 a month; its compounded tirzepatide, at $180, is 33% below the $269 median among the sellers we compare.
Before you pay Invyncible
Starting at $149 a month. Check today's price, then start the intake.
Where Invyncible is the wrong choice
No seller suits every reader, and pretending otherwise is the easiest way to sell one. On these three counts, another seller does better.
- If you need the FDA-approved pen rather than a compounded vial, consider WellMedRx.
- If the standing monthly cost is what decides it, consider Collective (from $59/mo + membership).
- If you want a human checking in, not just a prescription, consider Eden.
If none of these fits, our guide to alternatives to Invyncible sets more sellers in the same category beside Invyncible on price, states and what the price includes.
Frequently Asked Questions
How to check Invyncible yourself
- How to Verify an Online GLP-1 Pharmacy: Six Public Checks
- Is Ozempic Available Over the Counter? No GLP-1 Is, and What Is Sold Instead
- FDA Warning Letters to Peptide Sellers: What FDA Has Cited, 2023 to 2026
Every seller that ships to your state, side by side: Arizona, Georgia, Missouri, Nebraska, North Carolina, Tennessee, Washington, West Virginia and every other state.
Glossary
The words sellers use, defined. Tap any term.
- Semaglutide · Drugs and brands
- Tirzepatide · Drugs and brands
- Compounded GLP-1 · Pharmacy and drug forms
- 503A pharmacy · Pharmacy and drug forms
- PCAB accreditation · Pharmacy and drug forms
- Prior authorization (PA) · Insurance and regulatory
- Off-label use · Insurance and regulatory
- FDA Drug Shortage List · Insurance and regulatory
Sources
Cited across this Invyncible review: primary regulatory filings, and peer-reviewed studies.
Sources & methodology — as of October 2026
- 1.GLP Watchdog — GLP-1 Pricing Index 2026 (our independent dataset)— GLP Watchdog.
- 2.FDA — Compounding and the 503A Pharmacy Framework— U.S. Food & Drug Administration.
- 3.FDA — Drug Shortages Database (current shortage listings)— U.S. Food & Drug Administration.
- 4.PCAB — Pharmacy Compounding Accreditation Board Standards— Accreditation Commission for Health Care (ACHC) / PCAB.
- 5.KFF — Medicaid coverage research (anti-obesity & GLP-1 drug policy)— Kaiser Family Foundation.
- 6.STEP 1 Trial — Once-Weekly Semaglutide in Adults with Overweight or Obesity (Wilding JPH et al.)— New England Journal of Medicine.PMID: 33567185.
- 7.FDA — Wegovy (semaglutide) Approval History via Drugs@FDA— U.S. Food & Drug Administration.
- 8.FDA — Ozempic (semaglutide) Prescribing Information via Drugs@FDA— U.S. Food & Drug Administration.
- 9.SURMOUNT-1 Trial — Tirzepatide Once Weekly for the Treatment of Obesity (Jastreboff AM et al.)— New England Journal of Medicine.PMID: 35658024.
- 10.FDA — Zepbound (tirzepatide) Approval History via Drugs@FDA— U.S. Food & Drug Administration.
- 11.FDA — Mounjaro (tirzepatide) Prescribing Information via Drugs@FDA— U.S. Food & Drug Administration.
- 12.SURMOUNT-5 Trial — Tirzepatide vs. Semaglutide Head-to-Head in Obesity (Aronne LJ et al.)— New England Journal of Medicine.PMID: 40353578.
See Invyncible's current pricing
Plans start at $149 a month. Whether you qualify is a clinician's decision, made after your intake.